DXC Technology: Long-Term Targets Are Achievable

Analyst reiterates DXC Technology as a “Buy,” pointing to a path to positive revenue growth and meaningful operating margin expansion by FY2029. The thesis is supported by AI-driven offerings (OASIS) and cost optimization initiatives, while the stock trades at a low-single-digit forward P/E that is viewed as undemanding versus peers. Overall, the update is constructive but more valuation/trajectory commentary than a near-term catalyst.

Analysis

DXC is priced like a structurally declining asset, so the real debate is not whether AI helps margins at the margin, but whether it can change the terminal growth assumption. In IT services, AI usually arrives first as labor substitution, which can improve FCF before it improves revenue; that means the stock can work even if topline stays weak, but only if management proves it can keep more of the productivity gain than clients capture. The upside is a multiple re-rating from a depressed base; the downside is a classic value trap if the business remains a harvesting machine.

Second-order, any credible automation win should pressure peers with similar delivery models, especially CTSH and, to a lesser extent, IBM's services mix, because pricing discipline becomes harder if DXC can bid cheaper. But the market will not pay for long-dated FY2029 targets without nearer-term proof: bookings, sequential organic stabilization, and margin expansion in the next 2-4 quarters. If those do not show up, the low P/E can stay low or compress further as investors reclassify the story from turnaround to ex-growth.

The contrarian risk is that consensus is over-anchoring on AI as an earnings lever while ignoring that customers often use AI to reduce vendor spend. That makes the critical metric not "AI wins" but conversion to recurring revenue and retention of legacy contracts during the transition. Falsifier: another quarter of negative organic growth, flat backlog, or margin gains coming only from cost cuts rather than mix improvement.

Key Decisions for Investors

• Do not chase DXC on the article alone; wait for the next earnings cycle and only build a starter long if sequential organic revenue stabilizes and guidance is maintained or raised. Time horizon: 1-2 quarters. Falsifier: guide-down or continued revenue decline.
• If you want optionality on a turnaround, express it with a small 6-12 month DXC call spread rather than common stock. Risk/reward: limited premium at risk versus a potential multiple re-rate if the market starts discounting FY2029 earlier.
• Relative value only after confirmation: long DXC / short CTSH on evidence that DXC is converting AI-driven cost takeout into margin without losing share. Skip the pair if the next print shows weak bookings, because both names remain exposed to the same IT-spend cycle.
• Set an alert on DXC margins and backlog, not just revenue. If operating margin expands while backlog holds, the stock can rerate even without near-term top-line growth; if not, treat the low P/E as a value trap.